Shmuel Cabilly

Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.

Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel.

BioCep Ltd. develops cell separation technologies. The firm also manufactures and sells cutting-edge technologies for cell isolation. Its product, SmartSep enables cell recovery with magnetic beads removal process before infusion to the patient. The company was founded by Ofer Klein and Aharon Lamish on July 4, 2006 and is headquartered in Ness Ziona, Israel.

DenTack Implants Ltd. develops, manufactures and sells dental implants. Its products include implants, prosthetic components and surgical tools. The firm’s dental implants provide an implant solution for patients with short bone height as an alternative to surgical bone augmentation treatment. The company was founded by Oz Vachtenberg in 2006 and is headquartered in Kfar Saba, Israel.

Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel.

Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.

BioCep Ltd. develops cell separation technologies. The firm also manufactures and sells cutting-edge technologies for cell isolation. Its product, SmartSep enables cell recovery with magnetic beads removal process before infusion to the patient. The company was founded by Ofer Klein and Aharon Lamish on July 4, 2006 and is headquartered in Ness Ziona, Israel.

DenTack Implants Ltd. develops, manufactures and sells dental implants. Its products include implants, prosthetic components and surgical tools. The firm’s dental implants provide an implant solution for patients with short bone height as an alternative to surgical bone augmentation treatment. The company was founded by Oz Vachtenberg in 2006 and is headquartered in Kfar Saba, Israel.

Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.

Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.

Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel.

DenTack Implants Ltd. develops, manufactures and sells dental implants. Its products include implants, prosthetic components and surgical tools. The firm’s dental implants provide an implant solution for patients with short bone height as an alternative to surgical bone augmentation treatment. The company was founded by Oz Vachtenberg in 2006 and is headquartered in Kfar Saba, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel.

Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

BioCep Ltd. develops cell separation technologies. The firm also manufactures and sells cutting-edge technologies for cell isolation. Its product, SmartSep enables cell recovery with magnetic beads removal process before infusion to the patient. The company was founded by Ofer Klein and Aharon Lamish on July 4, 2006 and is headquartered in Ness Ziona, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel.

Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel.

Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel.

Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.

Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel.

Ofakim Hi-Tech Ventures Ltd. (Ofakim Hi-Tech Ventures) is a venture capital subsidiary of Capital Point Ltd. founded in 1991. The firm is headquartered in Ofakim, Israel.

Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel.

DenTack Implants Ltd. develops, manufactures and sells dental implants. Its products include implants, prosthetic components and surgical tools. The firm’s dental implants provide an implant solution for patients with short bone height as an alternative to surgical bone augmentation treatment. The company was founded by Oz Vachtenberg in 2006 and is headquartered in Kfar Saba, Israel.

Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel.

Ornim Medical Ltd. provides medical devices and monitering tools. The company is headquartered in Kfar Saba, Israel.

Pango Mobile Parking Ltd. provides parking payment and management system solutions. It offers mobile parking solutions and systems, location based services and mobile parking. The company was founded in 1995 and is headquartered in Kadima, Israel.

Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel.

Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel.